The 10th National Institute on the Civil False Claims Act and Qui Tam Enforcement

Nick O'Keefe and Christopher Swift break down how evolving U.S. regulations—CFIUS, FIRRMA, export controls, and outbound investment rules—are reshaping semiconductor deals, and highlighting risks and best practices for successful transactions.

Drug development can be slow, costly, and risky, often taking more than a decade and billions of dollars to bring a single therapy to the…

To ascertain which party in a commercial contract is responsible for tariffs, it is important to check whether the contract specifies the importer of record.